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Introduction 
Dendritic cells (DC) are a distinct lineage of unusually potent accessory cells for immune 
responses (reviewed in [1-4]) that are derived from CD34+ bone marrow precursors. They 
possess, or can acquire, the capacity to initiate primary adaptive immune responses in vitro 
and in vivo. This property is ascribed to expression of high cell surface levels of major histo-
compatibility complex (MHC) class II and costimulatory molecules. DC are required for the 
activation of naive T cells [S) and they also activate memory T cells. Evidence also exists 
however, for DC tolerogenicity. DC appear to playa critical role in central tolerance [6) and 
evidence has accumulated that, under defined experimental conditions, they can also induce 
systemic tolerance. DC lacking sufficient cell-surface expression of costimulatory molecules 
for naive T-cell activation, such as B7-1 (CD80) or B7-2 (CD86), induce alloantigen-specific 
anergy [7). Moreover, we have reported that, in mice, costimulatory molecule-deficient DC 
progenitors can promote the survival both of pancreatic islet [8] and organ allografts [9) in 
otherwise non-immunosuppressed hosts. There is also evidence that the cytokine microen-
vironment to which DC are exposed dictates the nature and magnitude of the resultant immune 
response. Thus, the 'immunosuppressive' cytokines - interleukin-lO (IL-lO) and transforming 
growth factor-f3 (TGF/3) - inhibit DC maturation, In addition, the chimeric fusion protein 
cytotoxic T-lymphocyte antigen-4 (CfLA-4)-Ig can markedly inhibit the capacity of DC to 
activate T cells. In addition, we have shown for the first time that DC induced to produce nitric 
oxide (NO) or that express Fas/Apo-l (CD9S) ligand (FasL) can inhibit growth and/or induce 
programmed cell death (apoptosis) in alloactivated T cells. This chapter reviews the immuno-
biology of DC in relation to organ transplantation with special emphasis on the conditions that 
may determine their tolerogenicity. 
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DC in commonly transplanted organs 
Members of the DC lineage arc thought to be distributed ubiquitously. Although DC isolated 
from lymphoid tissue have been studied extensively, we are only beginning to understand the 
properties of DC resident in commonly transplanted non-lymphoid organs, ie, kidney, liver 
and heart. The migration of DC from cardiac [1 OJ or liver allografts [11] to T-dependent areas 
of recipient spleens has been described in rodents, but there is little information on the func-
tional properties of these 'chimeric' cells or of the precursors from which they are derived. 
The best characterized DC isolated from non-lymphoid tissues of normal individuals are MHC 
class fI+ epidermal Langerhans cells (LC) [12J. When freshly-isolated, these cells have a 
phenotype distinct from that of 'mature' lymphoid tissue DC, and can process protein-contai-
ning antigens. They lack critical costimulatory molecules (B7-1 and B7-2) and thus cannot 
initiate responses in naive T cells. Sueh cells may have tolerizing potential. 
When cultured in granulocyte-macrophage-<:olony-stimulating factor (GM-CSF), LC can 
mature into cells resembling lymphoid tissue DC [13-16]: their phagocytic and antigen-
processing activities arc lost. They up-regulate cell-surface MHC class II antigen expression 
and become mature, potent antigen-presenting cells (APC) with costimulatory activity for 
T cells [16]. Recent evidence indicates that the expression of at least some costimulatory mole-
cules (B7-1 and B7-2) on LC is upregulated in conjunction with increased immunostimulatory 
function of mouse DC from spleen, skin, kidney and heart [17-19]. In various other non-
lymphoid tissues, including the respiratory tract, presumptive DC have been identified on the 
basis of their dendritic profiles and MHC class II expression [20, 21]. These potential migra-
tory cells are located, as in skin, below the epithelial lining, where they are ideally suited to 
acquire antigens (pathogens) [22J. In most cases, these non-lymphoid DC cannot stimulate 
primary T-cell responses (particularly, allogeneic mixed lymphocyte reaction[ (MLR). 
Recently, it has been shown that, like fresh LC, DC isolated from mouse kidneys and hearts 
cannot stimulate aIIogeneic T cells, unless cultured overnight [19]. These DC from non-
lymphoid organs thus resemble immature rather than mature DC. It is possible that the immu-
nostimulatory function reported for all DC isolated from non-lymphoid organs may be a 
consequence of in vitro maturation in culture. 
DC transport antigens rapidly from peripheral tissues, predominantly via lymph, but also 
apparently via blood, to regional (secondary) lymphoid tissues [23-25]. Upon arrival in 
lymphoid tissues, DC accumulate in the T cell-dependent regions, where they effectively 
prime antigen-specific immune responses. This ability to 'home' to sites ofT-cell activation is 
central to the identification of DC as potential immunomodulators of resistance to cancer or 
microbial infection and also of allograft rejection or autoimmune disorders. Homing affords 
DC with the opportunity to interact with the largest number of potential alloreactive T cells. 
In principle, the homing capacity of DC also provides an opportunity to deliver to the site of 
primary T-cell activation signals that are the result of DC manipulation. 
DC and tolerance induction 
While extensive studies have resulted in a greater understanding of the critical role of DC in 
the stimulation of primary immune responses, evidence has accumulated that DC can also play 
a role in tolerance induction (summarized in table I). 
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Table I. lbscrv~tiElns of the tolerogcnic capacity of dendritic cells (DC) 
Dendritic cell type Tolcrogcnic effect reported Reference 
Thymus DC 'J(,icrnnce acquired to host MIIC in chimeric thymi [2/i] 
Encephalitogen pulsing and adoptive transfer prevents EAE* [27J 
Splenic DC Reconstitution of DC-depicted f~hestores ability to delete 
thymocytes in vivo' " [6] 
Large numbers of DC reduce local HVO' reaction in vivo [28] 
Large numbers of DC/high antigen load inhibit antitumor immunity in vivo [29] 
CDK'/FasU DC induce apoptosis in activated T cells in vitro [30] 
Langerhans cells Depletion enhances cffector phasc of CII' in vivo [31] 
Pancreatic lymph-node DC Transfer reduces incidence of diabetes in NOD mice in vivo [32] 
Costimulator-deficicnt Induction of alloantigcn-spccific unresponsivcness in vitro [7J 
DC progenitors Adoptive transfer prolongs allograft survival in vivo [H, II, XII 
*EAE: experimental allergic encephalomyelitis,*UVG: host-versus-graft; CH: contact hypersensitivity, 
DC in central tolerance 
The thymus plays a major role in immune homeostasis by the deletion of self-reactive T cells, 
thus contributing to the maintenance of self-tolerance [34], A number of cell types present 
within the thymus including DC [26, 34] may potentially provide signals responsible for the 
negative selection of developing T cells (reviewed in [35,36]). However, two lines of evidence 
suggest that a substantial proportion of this activity is provided by thymic DC. When T cells 
differentiate in MHC-disparate thymus grafts depleted of bone marrow-derived APC, these T 
cells show only limited tolerance to the MHC antigens of the grafted thymuses [37, 38]. 
Matzinger and Guerder [6] outlined the critical role of DC in central tolerance by demonstra-
ting that the tolerogenic properties of the APC-depleted thymi could be restored by reconsti-
tution with purified splenic DC. Similar results have been reported in parents to F, bone 
marrow chimeras and in transgenic mice [39,40], These findings indicate that the role of DC 
in deleting potentially autoreactive developing T cells in the thymus is not dependent upon 
unique characteristics of the thymic DC, but may be mediated by signals provided by DC from 
other tissue sites [6]. More recent studies directed at investigating the possible amelioration of 
autoimmunity or allograft rejection have indicated that the tolerance exhibited following intra-
thymic inoculation of exogenous antigen is dependent upon thymic DC [41, 42]. Studies of 
lipopolysaccharide (LPS)-treated mice have suggested that NO production by presumptive 
thymic DC could represent one mechanism for thymocyte apoptosis and possibly self-tole-
rance [43]. These findings are consistent with our own recent observations of NO production 
by DC following treatment with interferon-y (IFN-y) or LPS or interaction with allogeneic T 
cells (see below and [44 D. 
DC and peripheral (systemic) tolerance 
While central tolerance may reflect the unique mture of the intrathymic environment or of 
T-cell development, more recent studies suggest that tolerance induction mediated by DC is 
not confined to the intrathymic compartment. Protection from autoimmunity induced by the 
encephalitogenic autoantigen myelin basic protein (MBP) can be achieved by intravenous 
injection of thymic DC either pulsed with the immunodominant peptide of MBP or isolated 
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from thymi inoculateu in vivo with MOP [27]. This protection was similar to that invoked by 
direct intrathymic inoculation of MOP [27]. The ability to induce tolerance is not restricted to 
thymic DC, as intravenous administration of antigen-pulsed LC or splenic DC has been repor-
ted to result in antigen-specific suppression of uelayed-type hypersensitivity responses [45, 
46], possibly via a mechanism involving selective activation of Th2-like T-cell subsets [47]. A 
further illustration of the ability of DC to shape a protective effect against autoimmunity has 
been provided by the dcmonstration that DC isolated from pancreatic lymph nodes of non-
obese diabetic (NOD) mice and transferred into pre-diabetic NOD mice can limit the expres-
sion of diabetes [32], possibly via a mechanism involving the enhanced induction of regula-
tory T cells. 
While the in vivo administration of DC via particular routes, or of certain DC populations, 
has resulted in the generation of tolerance or certain tolerance-like states, it is likely that the 
nature of on-going immune responses is dependent upon signals provided by DC. This sugges-
tion is consistent with observations that DC exhibit a dichotomous potential to regulate 
immune responsiveness. Thus, in vivo experimental studies have indicated that administration 
of DC loaded with low doses of tumor antigen can enhance anti-tumor immunity, while admi-
nistration of DC loaded with high doses of tumor antigen or administration of high numbers 
of tumor antigen-pulsed DC inhibit the development of protective anti-tumor immunity [291. 
Likewise, inoculation of high numbers of semi-allogeneic DC reduces the expression of host-
vs-graft reactivity in a local in vivo assay [281. Depletion of LC from epidermal surfaces of 
mice results in markedly stronger expression of the effector phase of contact hypersensitivity, 
suggesting these cells may provide both stimulatory and down-modulatory signals [31]. 
I! is possible that DC from specific peripheral tissue sites may possess the capacity to induce 
forms of tolerance whereby certain aspects of immune responsiveness are selectively inhi-
bited, while others remain intact. Thus, considerable evidence has accumulated that an APC 
bearing an antigen-specific signal migrates from the eye following administration of soluble 
antigen into the anterior chamber (AC) and results in the activation of regulatory T cells in the 
spleen. It is proposed that this phenomenon accounts for aspects of the 'immune-privilege' of 
the AC (reviewed in [48]) apparently via the selective activation of a Th2-type response [49]. 
Recent examination of the APC populations present in the tissues surrounding the AC has 
provided a strong indication that the APC migrating from the AC is an MHC class II-positive 
DC [50, 51]. It is likely that specific components of the local tissue microenvironment, for 
example the cytokine TGFf3 [48], are responsible for imparting DC with such properties, but 
the roles of various other microenvironmental influences on DC function remain to be clearly 
defined. Examination of other tissue sites may help to clarify this. There is also evidence that 
expression of immune unresponsiveness observed following application of antigen to mucosal 
surfaces (reviewed in [52, 53]) is the result of selective activation of T-cell subsets during 
primary immune stimulation. Whether DC from these tissue sites provide signals that result in 
the selective activation ofT-ceil subsets has not yet been determined, but on-going studies may 
help to elucidate the immunoregulatory role of these DC. 
Experimental manipulations rendering tolerogenicity to DC 
Experimental modulation of DC function, for example by exposure to ultraviolet (lTV) irr<l-
diation, the immunosuppressive chimeric fusion protein CrLA-4-Ig, or to the immunomodu-
latory effects of IL-lO, has also been reported to induce antigen-specific hyporesponsiveness 
in vitro [54, 55]. The relevance of such in vitro experimental treatments to the in vivo function 
IMMUNE TOLERANCE: 
4 JENNER. PASTEUR AND TIlEIR SUCCESSORS 
Jr 
I 
---------DK"-D-KD-K----K~--
nc immll1lo/iiology in organ transplantation 
of DC in conditions such as the tolerance that may be observed to UV-induced tumors is 
unclear. Interestingly, evidence is emerging that aiteration of the immunostimulatory capacity 
of DC by the cytokine miliell within tumors [56] may contribute to the tolerance often ob-
served with many tumor types [57J. Therefore, the ability to manipulate the tolerogenic poten-
tial of DC is likely both to further our understanding of immune regulation and to lead to 
potential therapeutic strategies to enhance allograft acceptance and suppress autoimmune disease. 
Molecular regulation of the immunologic activity of DC 
Studies examining the phenotypic characteristics of DC isolated from mouse thymus and 
spleen have demonstrated the presence of a major DC subpopulation in these tissues expres-
sing significant levels of CDS [58], comprised predominantly of the CD8a homodimer [58]. 
ft has been proposed that expression of the CD8 molecule by APC may provide these cells 
with a 'veto' function, enabling them to inactivate cytotoxic T-cell precursors with which they 
interact [59, 60J. Expression of this molecule by major subpopulations of thymus and spleen 
DC may allow these cells to perform a regulatory role in immune responsiveness by both 
presenting antigen and inactivating T cells [58]. While experimental evidence is yet to be 
provided confirming the role of CD8+ DC as veto celis, further work has demonstrated that the 
CD8a+ population of murine splenic DC express CD95L (FasL) and that these cells are 
capable of killing activated CD4 + T cells via Fas-FasL interactions [30]. The elucidation of the 
role of costimulation in T-cell activation (reviewed in [61]) has provided insight into one 
potential mechanism by which 'tolerogenic APC' may function. Our current understanding of 
T-cell activation indicates that presentation of antigen to T cells by APC in the absence of 
essential co-stimulatory signals induces a state of antigen-specific unresponsiveness (anergy) 
in these T cells [62], and thus also tolerance. Such a proposal leads to speculation that DC in 
peripheral tissue sites, which exhibit low levels of costimulatory molecule expression in the 
steady-state [18, 63]. may playa potentially important role in peripheral tolerance. Such a 
scheme would allow peripheral DC populations to perform a dual role, by contributing to the 
maintenance of peripheral tolerance in the steady-state, and also by acting as effective senti-
nels following activation signals, provided for example, by microbial products (reviewed in 
[64]). While experimental studies have yet to provide evidence, MHC class II-negative DC 
precursors described in the airway epithelium of adult rats [65], which are poor allostimula-
tors [66], and LC precursors described in the epidermis [67] may represent examples of endo-
genous popUlations of peripheral DC that possess the potential to function in such a manner. 
Recent studies from our laboratory support the notion that DC deficient in costimulatory 
signals may effect tolerance induction [7-9, 33]. Thus DC progenitors propagated in vitro 
from mouse bone marrow in the presence of low concentrations of GM-CSF express low 
levels of costimulatory molecules (B7-1/ow, B7 -2-) and induce alloantigen-specific unrespon-
siveness (anergy) in T cells in vitro [7]. This T-cell unresponsiveness induced by in vitro-
propagated costimulator molecule-deficient DC is not restricted to in vitro assays. Thus, admi-
nistration of these cells or costimulatory molecule-deficient DC propagated from the liver 
under similar conditions prolongs cardiac [9] or pancreatic islet [8] allograft survival. Like-
wise, DC on which the activity of surface B7-1 and B7-2 costimulatory molecules has been 
blocked by CTLA-4-Ig have been shown to protect animals from the induction of experimen-
tal allergic encephalomyelitis (EAE) [68]. It has also been suggested that rhesus monkey bone 
marrow-derived DC progenitors (MHC class II-Idim, CD8+) may exert tolerance promoting 
activity both in vitro and in vivo [69]. 
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DC and impaired allogeneic T-cell responses (a-i) 
Over the past several years, we have established model systems that have allowed us evaluate, 
both in vitro and in vivo, factors that regulate DC growth, phenotype and function. These data 
are now summarized in the context of both the interaction of these cells with allogeneic T cells 
and the potential tolerogenicity of DC. 
a) Growlh of dOl/or-derived DC from Ihe lymphoid tisslle of spontaneously tolerant mouse 
liver allugraft recipients /70J 
Livers are accepted 'spontaneously' (without immunosuppression) between many MHC mis-
matched mouse strains r 11]. We hypothesized that DC progenitors might be seeded from the 
liver graft to recipient lymphoid tissues after orthotopic liver transplantation. To test this hypo-
thesis, bone marrow or spleen cells were isolated from unmodified mouse orthotopic liver 
transplant (OLTx) recipients (male BlO [e-Ohz~female C3H [H-2kJ) 14 days after transplan-
tation. The cells \vere cultured for 10 days in GM-CSF, employing the techniques developed 
in our laboratory to enrich for DC lineage cells. Using flow cytometric and immunocytoche-
mical analyses for donor MHC class 1+ and II+ cells, respectively, a minor population of cells 
of donor phenotype (in addition to recipient cells) was found to propagate in culture. 
Radioactive polymerase chain reaction (PCR) analysis, using a probe specific to the sex-deter-
mining region of male donor Y chromosome, revealed growth of cells of donor origin in bone 
marrow (especially) and in spleen cell cultures propagated from female recipients of male 
livers. No signal for donor-derived cells could be detected in 10-day GM-CSF-stimulated 
cultures of thymocytes from liver-allograft recipients. This suggested that, although the 
thymus is a site in which chimeric cells are detected after OLTx, it may not be a destination 
for adequate numbers of donor-derived DC progenitors. We next sought direct evidence that 
the donor-derived cells propagated from the bone marrow of liver-allograft recipients were of 
DC lineage. Sorting of donor-positive cells was considered, but the anticipated yield of cells 
was calculated to be too low for subsequent functional analysis. Instead, lO-day GM-CSF-
stimulated bone marrow-derived cells were harvested, DEC 205+ cells were sorted (at least 
90% purity by morphological and FACScan® analyses) and then investigated for the presence 
of donor Y chromosome. PCR analyses demonstrated convincingly that the highly purified 
DC population comprised approximately 1-10% Y-chromosome positive (donor-derived) DC. 
Further evidence for the presence of donor-derived DC was obtained by testing the allostimll-
latory activity of sorted, DEC 205+ GM-CSF+IL-4-stimulated bone marrow-derived cells in 
primary MLR. Here, IL-4 was used to promote ex vivo DC maturation, since this was neces-
sary for the detection (exhibition) of allostimulatory activity. The purified DEC 205+ popu-
lation propagated from C3H recipients of 810 allografts strongly stimulated BIO (donor 
strain) responders, but also stimulated a response in recipient strain (C3H) T cells. The extent 
of stimulation (P < 0.01 compared with negatively sorted cells or syngeneic DC) was similar 
to Ihat achieved with 'artificial mixtures' containing 1 % GM-CSF+IL-4-stimulated donor 
strain (810) DC [70). 
A key additiona l ouservation was our failure to propagate dOllor-derived cells from the bone 
marrow of mice rejecting heart allografts. In contrast to liver-allograft recipients, non-immu-
nosuppressed C3H mice reject heart allografts from the same donor strain (BlO) within 8 days 
[11]. PCR analysis for donor Y chromosome was performed on IO-day GM-CSF-stimlliated 
cultures of hone marrow cells harvested from heterotopic cardiac allograft recipients 8 days 
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after transplant. In contrast to the results obtained from liver-graft recipients, no evidence was 
obtained for the propagation of donor-derived cells from the bone marrow of animals rejecting 
their cardiac grafts, despite evidence of small numbers of chimeric cells in freshly-isolated 
bone marrow. Thus heart-derived cells, in contrast to those detected in fresh bone marrow of 
liver-allograft recipients, appear not to contain sufficient numbers of GM-CSF-responsive 
progenitors for growth of donor-derived cells (as opposed to amplification in the case of liver 
grafts) after 10 days of culture. These findings suggest that donor-derived alloantigen-presen-
ting DC progenitors may playa key role in the induction of organ transplant tolerance. 
b) DC deficielll ill cell slIIface expression ofT-cell costimulatOlY molecules (B7-], B7-2) 
illdllce T-cell liYfJorcSPOIlSil"£'llCSS (allergy) in vitro f7J 
DC were propagated from B 1 0 mouse bone marrow in GM-CSF or GM-CSF + IL-4, as 
described [7]. Cells propagated in GM-CSF + IL-4 exhibited potent allostimulatory activity in 
primary mixed leukocytes cultures. In contrast, the cells stimulated with GM-CSF alone were 
very weak stimulators. They induced alloantigen-specific hyporesponsiveness in allogeneic 
T cells (C3H) detected upon restimulation in secondary MLR. This was associated with bloc-
kade of IL-2 production. Reactivity to third party stimulators was intact [7]. The hyporespon-
siveness induced by the GM-CSF-stimulated, costimulatory molecule-deficient DC progeni-
tors was prevented by incorporation of anti-CD28 monoclonal antibody (mAb) into the 
primary MLR. It was reversed by the addition of IL-2 to restimulated T cells. These findings 
show that MHC class IJ+ B7-2- DC progenitors can induce alloantigen-specific hyporesponsi-
veness in T cells in vitro. Under the appropriate conditions, donor-derived, costimulatory 
molecule-deficient DC progenitors could therefore contribute to the induction of donor-speci-
fic unresponsiveness in vivo. 
c) CostimulatOlY molecule-deficient DC prolong the survival of pancreatic islet allografts ill 
nOIl-immullosuppressed recipients ;n a donor-specific manner [8J 
We have tested the in vivo relevance and therapeutic potential of cultured DC progenitors 
(MHC class W, B7-2-/dim) in a pancreatic islet-allograft model. Tv,Io days after rendering 
groups of BIO (H-2b) mice diahetic with streptozotocin and 7 days before transplantation with 
800 islets (99% pure) under the left renal capsule, the animals received iv either culture 
medium, 2.5 x 106 allogeneic (Bl O.BR; H-2k) or syngeneic, lO-day cultured, GM-CSF-stimu-
lated DC progenitors (immature DC) or 10-day cultured, GM-CSF-stimulated mature spleen 
DC. Blood glucose and body weights were recorded daily. The GM-CSF-stimulated DC 
progenitors prolonged allograft survival from 11.9 ± 0.9 days (control) to 30.3 ± 17.1 days 
(P < 0.001). 
d) MHC class 1/+ B7-2- DC progenitors prolong cardiac allograft survival in lIoll-immuno-
suppressed hosts f9J 
We have also found that GM--CSF-stimulated DC progenitors (B7-2-) capable of inducing 
T-cell hyporesponsivencss lJJ vitro, can prolong heart-allograft survival. In the BI0-C3H 
model, 2 x 106 B7-2- B I 0 DC progenitors were injected iv 7 days before transplantation. 
These cells significantly prolonged heart graft survival from 10.1 ± 2.2 (control) to 23.3 ± 5.5 
days compared with syngeneic (C3H; 12.5 ± 0.6 days) or third party cells (BALB!c; 16.S ± 
2.8 days (P < 0.0 I). 
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In contrast and as expected, mature (137-2+) DC reduced mean graft survival time. The non-
specific effect of third party DC progenitors (although significantly less than that of allogeneic 
cells) is of interest, but at present not understood; one simple explanation is that the C3H anti-
1310 and C3H anti-BALB/c responses are partially cross-reactive so that BALB/c DC proge-
nitors partially tolerize the anti-BlO response. We are pursuing this finding and plan to include 
third party controls in all such future experiments testing in vivo DC function. 
e) DC treated with an immunosuppressive cytokille (TGFf3) exhibit markedly depressed 
ability to stimulate lIaive allogel/eic T cells 
Two prototypic genes that we are presently transferring into DC are those which encode ;lIL-
10 and TGF{3. Preliminary studies were performed to evaluate the likely effects of TGFf3 
production by gene-engineered DC on their allostimulatory capacity in vitro. Mature (GM-
CSF + IL-4-propagated) mouse (CS7BL/1O) bone marrow-derived DC exposed til~dcfP1 
(0.1 nglml) for a period of 18 h exhibited a markedly reduced ability to stimulate a primary 
allogeneic MLR when compared to untreated controls (fig 1). 
j) Blockade of costimllllllory B7 molecule expression all DC using the chimeric fusion 
protein CTLA·4-Ig suppresses T-cell allostimulatory activity in a dose-dependent manlier 
The interaction of CD28 on T cells with CD28 counter-receptors on APC provides critical 
costimulatory signals that are required for T-cell activation. We have demonstrated that mouse 
DC deficient in CD28 counter-receptors (DEC 20S+, B7-110w[CD80Iow], B7-2-[CD86-D are 
able to induce T-ccil hyporesponsiveness in vitro and, when adoptively transferred into normal 
mice, can extend the survival of pancreatic islet allografts and cardiac allografts. Blockade of 
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Fig 1. Allostimulatory activity of mouse 
DC exposed to TGF{:l. DC were propaga-
ted from bone marrow (C57BUlO) in 
the presence of GM-CSF + IL-4. harves-
ted (d 5) and washed (2x). Following 
/ overnight culture in RPMI/IO% FCS + 
/, (rrn)JM-CSF (4 nglmL) in the presence or 
\1 absence o((rtfGF{:ll (0. I nglml) DC 
A.. were was:fied (2x). Three·day MLR 
10 100 
cultures were estobiishcd using 2 z 105 
allogeneic (B10.BR) nylon WI)o!·passJ-
ged spleen cells and graded n:Jmbers nf 
y·irradiated DC. Data presented are 
mean [311]TdR incorporations of tripli-
cate cultures. Number or DC added (x1O- 3) 
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CD28 counter-receptors with the chimeric fusion protein mCTLA-4-Ig inhibits the in vitro 
allostimulatory of bone marrow-derived GM-CSF + IL-4-propagated murine DC. Addition of 
CfLA-4-Ig to primary one-way MLR cultures (fig 2A) resulted in marked dose-dependent 
reduction of the proliferation of allogeneic T cells observed in this system. Pre-incubation of 
DC with CTLA-4-Ig (at the submaximal dose of 100 nglml) also markedly reduced the ability 
of DC to stimulate naive allogeneic T cells (data not shown). 
g) Highly purifled DC call be illduced by IFNy or LPS to synthesize nitric oxide (NO) 
synthase (NOS); NO prodllction suppresses allogeneic T-cell proliferation ill MLR alld 
indllces apop/osis both ill activated T cells alld DC themselves [44J 
NO is an important effector molecule involved in immune regulation and host defense. We 
have recently found that highly purified DEC 205+ MHC class IInright B7-2+ DC propagated 
from normal mouse bone marrow in response to GM-CSF + IL-4 can be induced to produce 
NO by IFNyor LPS. NO production was inhibited by the NOS inhibitor, NG-monomethyl-L-
arginine (NMMA). Similar amounts of N02- were detected in supernatants of IFNy (±LPS)-
stimulated B7-2- DC. Nitrite also accumulated in mixed leukocyte-culture supernatants as the 
result of coculture of DC with purified naive allogeneic T cells. Suboptimal T-cell proliferation 
observed at high relative concentrations of DC correlated with increased NO production and 
was mitigated by NMMA. Induction of mRNA for an inducible (i) NOS in DC was confirmed 
by Northern blotting, whereas intracellular iNOS was visualized by 2-color flow cytometry 
and by both immunofluorescent and immunogold labeling in a subpopulation of IFNy- and 
LPS-stimulated cells. Both endogenous NO production and exposure of unstimulated DC to 
the NO donor S-nitroso-N-acetylpenicillamine (SNAP) resulted in DC apoptosis. Thus, 
although DC function initially as the most potent APC for T-cell activation, DC induced to 
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Fig 2. Blockade of the B7-CD28 pathway augmcfits apoptosis induced in allogeneic T cells by DC. MLR wllures 
were established with graded concentrations of bone marrow·derived DC (BI0.BR) and allogeneic (CS7BUto) sple-
nic T cells (2 x 105). A. Blockade of B7-CD28 interactions with lOOO nglml CfLA-4-Ig was effective in providing 
almost complete inhibition of T-cell proliferation. B. Blockade of B7-CD28 interactions by treatment of DC with 
1000 nglmL CfLA-4-Ig also resulted in a marked increased in DNA fragmentation of allogeneic T cells in MLR 
cultures, compared with untreated DC. 
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synthesize NOS by IFNy may inhibit (allogeneic) T-cell proliferation: NO may suppress 
lymphocyte proliferation and also induce apoptosis of the most potent source of alloantigenic 
stimulation. 
11) Sorted DC propagated [rom mouse bone marrow express Fas (CD95) ligand alld call 
induce apoptosis in alloactivated T cells 
During primary activation, mature T cells change from an activation-induced cell death 
(AICD)-resistant to an AICD-sensitive phenotype. The complete molecular basis for this tran-
sition remains to be determined, but CD95 (Fas/Apo-l) and CD95L (Fas ligand; FasL) appear 
to play an important role in the homeostatic regulation of T-cell responses. We have recently 
determined that certain DC populations can induce T-cell apoptosis through CD95 ligation and 
that costimul::ttory molecule expression on DC affects apoptosis of T cells induced by these 
APC. Highly purified DEC 205+ MHC class IIbrighl B7-2+ DC propagated from normal mouse 
bone marrow in culture medium containing GM-CSF+IL-4 express significant cell-surface 
levels of CD95L, as shown by immunocytochemical staining and FACS analysis using Fas-Fc 
fusion protein (provided by David II Lynch PhD, Immunex, Scattle, WA, USA) and reverse 
transcripl<lse-PCR. 
'" i) CTLA-4-1g-treated 'mjJa(lIre' DC i/lduce higher levels of apoptosis in allogeneic T cells 
(han [lilly dijJcrelltiated'f1c 
Bone marrow-derived DC were tested for their capacity to induce apoptosis in Can A- or 
alloantigen-activated T cells by DNA fragmentation and in situ TdT-catalyzed DNA nick-end 
labeling (TUNEL) assay. Inclusion of murine CfLA-4-Ig (a molecule that blocks the 
B7-CD28 costimulatory pathway) into cultures of DC and activated T cells resulted in an 
increased level of apoptosis in the allostimulated T cells both in short- (4 h) and long-term 
(18 h) cultures (fig 2B). A role for CD95L is suggested by the observation that DC propaga-
ted from CD95L-defective B6-gld mice do not induce significant levels of apoptosis in 
cultures of alloactivated T cells. These findings suggest that B7/CD28 and CD95/CD95L 
interactions may playa key role in regulating the outcome of allogeneic DC-T-cell interaction. 
Conclusion 
These observations provide evidence that DC whose allostimulatory function is impeded 
either by incomplete phenotypic maturation, selective blockade of costimulatory molecules 
(eg, using CTLA-4-Ig) or the influence of specific cytokine-gene products (ie, IL-lO, TGFfJ) 
exhibit activity consistent with the induction of tolerance rather than an immunogenic DC 
function. In addition. the expression by DC of key molecules associated with inhibition of 
T-cell growth or induction/T-cel\ apoptosis (ie, NO, FasL) suggests that these important APC 
have potential to impose rg~traint on immune reactivity. 
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